Dnca Finance »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Dnca Finance

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Dnca Finance from 13F filings

Historical chart of Dnca Finance investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Dnca Finance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Dnca Finance

Quarter filed Position value Share count Share price at filing
2024-09-30 $421k 370k 1.14

More positions owned by Dnca Finance

Flutter Entmt SHS (FLUT)
Crh Plc O Ord (CRH)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ferrari Nv Ord (RACE)
Linde SHS (LIN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Deere & Company (DE)
Alphabet Cap Stk Cl A (GOOGL)
Trane Technologies SHS (TT)
Spotify Technology S A SHS (SPOT)
Broadcom (AVGO)
Amazon (AMZN)

View all positions for Dnca Finance

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1